Illumina, Inc. (NASDAQ:ILMN) today unveiled its new HumanOmniExpress+
Custom BeadChip (OmniExpress+), an enhancement to the recently announced
OmniExpress BeadChip that allows for the addition of up to 200,000
custom variants for a total of >900k variants per sample. OmniExpress+
leverages the proven iSelect custom genotyping infrastructure to provide
researchers with unlimited flexibility in adding custom content for
disease or pathway-specific markers, rare variants from the 1,000
Genomes Project, or panels for fine-mapping onto the industry’s most
optimal set of SNPs.
“The OmniExpress+ continues Illumina’s tradition of supporting
semi-custom products, joining the ranks of the 300-Duo+, 550-Quad+ and
many others”
"The OmniExpress+ continues Illumina’s tradition of supporting
semi-custom products, joining the ranks of the 300-Duo+, 550-Quad+ and
many others,” said Jay Flatley, president and CEO of Illumina. “This
addition to our family of third generation arrays leverages our many
years of successful custom genotyping projects. The ability to add 3,000
to 200,000 custom variants to the standard OmniExpress provides
tremendous flexibility to researchers while accessing the most optimal
set of SNPs currently available for genome-wide association studies.”
The HumanOmniExpress+ Custom BeadChip is the most versatile custom
genotyping product available, with industry-standard data quality
ensured by the robust Infinium assay, flexible content design, and high
throughput capabilities supported by a multisample BeadChip. Similar to
researchers currently using iSelect, OmniExpress+ users will have access
to Illumina’s assay design software for seamless content design,
ensuring the best assay success rate in the industry without the need to
pre-screen.